Fundz

GC Aesthetics announces a decade-long clinical assessment of the PERLE™ breast implant, aimed at ensuring safety and patient satisfaction.

Dec 18, 2024
IrelandBiotechnologyHealth CareMedicalMedical Device

Product Description

GC Aesthetics has initiated an important multi-center prospective clinical study in Europe to evaluate and confirm the safety, effectiveness, and patient satisfaction of the innovative PERLE™ smooth, opaque round breast implant. This comprehensive study involves top surgeons from the NHS and private clinics across Europe, ensuring a robust and diverse dataset.

Company Information

Company

GC Aesthetics

Location

Ireland

About

GC Aesthetics® (GCA) is a private medical technology company providing aesthetic and reconstructive solutions for the global healthcare market. The company prides itself on its innovative products, including the refined PERLE™ breast implant, designed with advanced technology for enhanced safety and patient satisfaction. GCA is committed to setting new standards in breast implant technology and patient care through rigorous clinical research. They aim to continually meet the evolving needs of patients and surgeons worldwide.

Fundz sees it the moment GC Aesthetics ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Steve hidden

hidden

Danilo hidden

Syed hidden

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for GC Aesthetics's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

GC Aesthetics shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.